In March 2020, the World Health Organization declared a pandemic due to the emergence of SARS-CoV2, which causes COVID-19, a potentially lethal respiratory infection. To date, apart from the novel Molnupiravir and Ritonavir, there are no orally or nasally administered antiviral agents to prevent or treat SARS-CoV2 infections.
This project seeks to contribute to the amplification of the results and impact of the “Better sexual and reproductive health and rights for adolescent girls in Senegal – ADOS” program, through support to five youth organizations working to improve the sexual and reproductive health of adolescent girls on a national level in Senegal.
The overall objective of this project is to encourage the use of research results and innovations generated through the implementation of the program “Better sexual and reproductive health and rights for adolescent girls in Senegal” to ensure better sexual and reproductive health of adolescent girls and to effectively protect them from gender-based violence.
This project seeks to amplify the results and impact of the ADOS program by supporting five youth organizations working to improve the sexual and reproductive health of adolescent girls at the national level in Senegal.
Recent outbreaks of the highly infectious and dangerous Ebola virus in West and Central Africa underscore the importance of rapid diagnostics and surveillance infrastructure, evidence-driven health communications and community engagement activities, and an effective and well-coordinated emergency response to strengthen the resilience of vulnerable populations in the face of emerging pandemic threats.